add items to your
binder to email or
print all at once
Items In Binder
Site Lawyers
 
Mylan Inc.'s $1.5 Billion Senior Notes Offering

Cravath represented Mylan Inc. in connection with its $1.5 billion 144A/Reg. S senior notes offering. Mylan Inc. is a wholly owned subsidiary of Mylan N.V., a leading global pharmaceutical company that develops, licenses, manufactures, markets and distributes generic, branded generic and specialty pharmaceuticals. The transaction closed on April 9, 2018.

The Cravath team included partner Johnny G. Skumpija and associates Alex M. Dzioba and Justin B. Stein on securities matters, and associate Kiran Sheffrin on tax matters. Jeffrey M. Amico also worked on securities matters.